137 related articles for article (PubMed ID: 9732842)
1. [Tissue polypeptide antigen and carcinoembryonic antigen in bladder neoplasms].
Krajewska B; Stelmach W; Lutz W; Matych J
Med Pr; 1995; 46(1):7-16. PubMed ID: 9732842
[TBL] [Abstract][Full Text] [Related]
2. Determination of tissue polypeptide antigens (TPA) and carcinoembryonic antigen (CEA) in serum: its value in the preliminary cancer risk assessment in asbestos exposed workers.
Lutz W; Krajewska B; Piłacik B
Int J Occup Med Environ Health; 1997; 10(3):259-65. PubMed ID: 9524403
[TBL] [Abstract][Full Text] [Related]
3. [Changes in the levels of tissue polypeptide antigen and carcinoembryonic antigen in the blood of workers exposed to aromatic amines].
Lutz W; Krajewska B
Med Pr; 1992; 43(4):297-301. PubMed ID: 1453945
[TBL] [Abstract][Full Text] [Related]
4. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
Pan QR; Zhang X; Xu ZF; Zheng S
Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
[TBL] [Abstract][Full Text] [Related]
5. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
Buccheri G; Ferrigno D
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793
[TBL] [Abstract][Full Text] [Related]
6. Comparison between tissue antigen analysis and plasma determinations for TPA and CEA in transitional cell carcinomas and in tumorfree urothelium of the urinary bladder.
Vogel J; Oehr P; Maisey R; Adolphs HD
Cancer Detect Prev; 1988; 11(3-6):389-96. PubMed ID: 2455597
[TBL] [Abstract][Full Text] [Related]
7. [Advances regarding tumor markers in bladder cancer].
Moreno Sierra J; Chicharro Almarza GJ; Torronteras Santiago JM; Ortega Heredia MD; Maestro de las Casas ML; Silmi Moyano A; Resel Estévez L
Actas Urol Esp; 1997 Mar; 21(3):195-205. PubMed ID: 9324884
[TBL] [Abstract][Full Text] [Related]
8. Tissue polypeptide antigen (TPA) in comparison with mutations of tumour suppressor gene P53 (TP53) in patients with bladder cancer.
Ecke TH; Lenk SV; Schlechte HH; Loening SA
Anticancer Res; 2003; 23(2A):957-62. PubMed ID: 12820330
[TBL] [Abstract][Full Text] [Related]
9. [Exposure to asbestos and levels of selected tumor biomarkers].
Krajewska B; Lutz W; Piłacik B
Med Pr; 1996; 47(2):89-96. PubMed ID: 8657007
[TBL] [Abstract][Full Text] [Related]
10. Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothelial growth factor (VEGF) in follow-up of breast cancer.
Findeisen R; Albrecht S; Richter B; Deutschmann K; Zimmermann T; Distler W
Luminescence; 2000; 15(5):283-9. PubMed ID: 11038485
[TBL] [Abstract][Full Text] [Related]
11. Relationship between tissue and serum concentrations of carcinoembryonic antigen (CEA) in gastric and colonic carcinomas.
Rosandić-Pilas M; Hadzić N; Stavljenic A; Juricić M; Scukanec-Spoljar M
Acta Med Austriaca; 1990; 17(5):89-93. PubMed ID: 2092570
[TBL] [Abstract][Full Text] [Related]
12. Assessment of biological variation and analytical imprecision of CA 125, CEA, and TPA in relation to monitoring of ovarian cancer.
Tuxen MK; Sölétormos G; Petersen PH; Schioler V; Dombernowsky P
Gynecol Oncol; 1999 Jul; 74(1):12-22. PubMed ID: 10385546
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of biological tumor markers for early detection of neoplastic changes in the bladder of persons exposed to aromatic amines].
Hanke J; Krajewska B; Lutz W
Med Pr; 1989; 40(6):376-80. PubMed ID: 2698439
[TBL] [Abstract][Full Text] [Related]
14. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
15. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
Foa P; Fornier M; Miceli R; Seregni E; Santambrogio L; Nosotti M; Cataldo I; Sala M; Caldiera S; Bombardieri E
Anticancer Res; 1999; 19(4C):3613-8. PubMed ID: 10629660
[TBL] [Abstract][Full Text] [Related]
16. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
[TBL] [Abstract][Full Text] [Related]
18. Serum tissue polypeptide antigen (TPA): monoclonal or polyclonal radio-immunometric assay for the follow-up of bladder cancer.
Bennink R; Van Poppel H; Billen J; Decoster M; Baert L; Mortelmans L; Blanckaert N
Anticancer Res; 1999; 19(4A):2609-13. PubMed ID: 10470203
[TBL] [Abstract][Full Text] [Related]
19. Clinical effectiveness of tumor markers in squamous cell carcinoma of the larynx.
Eleftheriadou A; Chalastras T; Ferekidou E; Kyriou L; Yiotakis I; Pappas Z; Ferekidis E; Kandiloros D
Anticancer Res; 2006; 26(3B):2493-7. PubMed ID: 16821638
[TBL] [Abstract][Full Text] [Related]
20. Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization.
Bombardieri E; Jotti GS; Cocciolo MG; Mori M; Rusconi A; Rusca M; Seregni E; Becchi G; Fontanesi M; Tardini A
Cancer Detect Prev; 1985; 8(1-2):219-26. PubMed ID: 4064041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
